| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.092 | 0.1 |